Monograph

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on 2 rounds in the feed, most often at Series A.

Rounds from 2025-01-10 to 2026-06-24

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$235M

across 2 rounds

LATEST ROUND

Series A · $115M · 2026-06-24

CO-INVESTORS

named beside it

Rounds

[ 2 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

Company	Round	Amount	Announced	Role
RQ Bio Series A	Series A Verified against 1 of 6 sources[ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts.	$115M	2026-06-24	[ PART ]
Ouro Medicines Ouro Medicines develops treatments for immune-mediated diseases, targeting patients with such conditions.	Series A Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$120M	2025-01-10	[ PART ]